CH611292A5 - - Google Patents

Info

Publication number
CH611292A5
CH611292A5 CH494875A CH494875A CH611292A5 CH 611292 A5 CH611292 A5 CH 611292A5 CH 494875 A CH494875 A CH 494875A CH 494875 A CH494875 A CH 494875A CH 611292 A5 CH611292 A5 CH 611292A5
Authority
CH
Switzerland
Application number
CH494875A
Inventor
Paul Edward Aldrich
Gilbert Harvey Berezin
Bruce Ivor Dittmar
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of CH611292A5 publication Critical patent/CH611292A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
    • C07D331/04—Four-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/46—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom
    • C07D333/48—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings substituted on the ring sulfur atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH494875A 1974-04-17 1975-04-17 CH611292A5 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46169974A 1974-04-17 1974-04-17
US05/555,307 US4009847A (en) 1974-04-17 1975-03-11 1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents

Publications (1)

Publication Number Publication Date
CH611292A5 true CH611292A5 (cs) 1979-05-31

Family

ID=27040095

Family Applications (1)

Application Number Title Priority Date Filing Date
CH494875A CH611292A5 (cs) 1974-04-17 1975-04-17

Country Status (21)

Country Link
US (1) US4009847A (cs)
JP (1) JPS50148349A (cs)
AR (1) AR208545A1 (cs)
CA (1) CA1047042A (cs)
CH (1) CH611292A5 (cs)
DD (1) DD117223A5 (cs)
DE (1) DE2516554A1 (cs)
DK (1) DK164175A (cs)
ES (1) ES436648A1 (cs)
FI (1) FI751128A7 (cs)
FR (1) FR2267773B1 (cs)
GB (1) GB1461209A (cs)
HU (1) HU173052B (cs)
IE (1) IE41143B1 (cs)
IL (1) IL47095A (cs)
LU (1) LU72306A1 (cs)
NL (1) NL7504570A (cs)
NO (1) NO144071C (cs)
PH (1) PH11722A (cs)
SE (1) SE417965B (cs)
YU (1) YU96075A (cs)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4156738A (en) * 1977-10-07 1979-05-29 E. I. Du Pont De Nemours And Company Ureidonitriles useful as antihypertensives
US6344476B1 (en) * 1997-05-23 2002-02-05 Bayer Corporation Inhibition of p38 kinase activity by aryl ureas
US6187799B1 (en) * 1997-05-23 2001-02-13 Onyx Pharmaceuticals Inhibition of raf kinase activity using aryl ureas
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
HK1042251B (en) * 1999-01-13 2012-07-20 Bayer Healthcare Llc Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
RU2319693C9 (ru) * 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
EP1140840B1 (en) 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
RU2316326C2 (ru) * 2001-12-03 2008-02-10 Байер Фамэсьютиклс Копэрейшн Способ и композиция для лечения ракового заболевания, тозилат и фармацевтически приемлемые соли n-(4-хлор-3-(трифторметил)фенил)-n'-(4-(2-(n-метилкарбамоил)-4-пиридилокси)фенил)мочевины
US20080108672A1 (en) * 2002-01-11 2008-05-08 Bernd Riedl Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
EP2324825A1 (en) 2002-02-11 2011-05-25 Bayer Healthcare LLC Aryl ureas with angiogenesis inhibiting activity
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
ES2378670T3 (es) 2002-02-11 2012-04-16 Bayer Healthcare, Llc Aril ureas como inhibidores de cinasas
AU2003210969A1 (en) * 2002-02-11 2003-09-04 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
JP4860474B2 (ja) * 2003-05-20 2012-01-25 バイエル、ファーマシューテイカルズ、コーポレイション Ｐｄｇｆｒによって仲介される病気のためのジアリール尿素
AU2004259760B9 (en) * 2003-07-23 2011-02-03 Bayer Healthcare Llc Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
EP2295427A1 (en) * 2004-04-30 2011-03-16 Bayer HealthCare, LLC Substituted pyrazolyl urea derivatives useful in the treatment of cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH452475A (de) * 1965-05-20 1968-05-31 Bayer Ag Verfahren zum Färben und Bedrucken von synthetischem Textilmaterial mit Anthrachinonfarbstoffen

Also Published As

Publication number Publication date
NO751351L (cs) 1975-10-20
NO144071C (no) 1981-06-17
DK164175A (da) 1975-10-18
AR208545A1 (es) 1977-02-15
LU72306A1 (cs) 1976-03-17
NO144071B (no) 1981-03-09
FI751128A7 (cs) 1975-10-18
HU173052B (hu) 1979-02-28
SE417965B (sv) 1981-04-27
DD117223A5 (cs) 1976-01-05
IL47095A0 (en) 1975-06-25
US4009847A (en) 1977-03-01
FR2267773A1 (cs) 1975-11-14
AU8013575A (en) 1976-10-21
JPS50148349A (cs) 1975-11-27
FR2267773B1 (cs) 1978-08-18
YU96075A (en) 1983-04-27
NL7504570A (nl) 1975-10-21
CA1047042A (en) 1979-01-23
PH11722A (en) 1978-05-30
IE41143L (en) 1975-10-17
DE2516554A1 (de) 1975-10-30
IE41143B1 (en) 1979-10-24
ES436648A1 (es) 1977-08-01
SE7503523L (sv) 1975-10-20
IL47095A (en) 1978-03-10
GB1461209A (en) 1977-01-13

Similar Documents

Publication Publication Date Title
FR2258716A1 (cs)
FR2259981B1 (cs)
FR2267773B1 (cs)
FR2258167A1 (cs)
AU480152B2 (cs)
DK142816C (cs)
FI752048A7 (cs)
FR2260129A1 (cs)
FR2261374B3 (cs)
FR2261637B1 (cs)
AR199134A1 (cs)
AU471463B2 (cs)
AR198786Q (cs)
CS173227B1 (cs)
CS172747B1 (cs)
CS173215B1 (cs)
AU479931A (cs)
AU480470A (cs)
AU480580A (cs)
AU480762A (cs)
AU479629A (cs)
AU482244A (cs)
AU480863A (cs)
DD116380A1 (cs)
AU481001A (cs)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased